Emerging DPP-4 Inhibitors: Focus on Linagliptin for Type 2 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - New Zealand
doi 10.2147/dmso.s23166
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Informa UK Limited